LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/San Diego Spine Company “World’s Most Innovative Company”
Company News

San Diego Spine Company “World’s Most Innovative Company”

May 4, 2023 2 min read Premium comments

Advertisement

San Diego Spine Company “World’s Most Innovative Company”
Xenco Medical Founder and CEO Jason Haider receiving Fast Company’s Most Innovative Companies Award on behalf of Xenco Medical. / Courtesy of Xenco Medical
#cervicalspineSecondary#xencomedical

Is San Diego, California, and its environs the new capital of spine surgery innovation and manufacturing?

NuVasive, Alphatec, SeaSpine (now part of Orthofix), Aurora Spine, and a handful of other interesting spine companies are creating a Spine Valley in that beautiful part of the world.

One of those firms, Xenco Medical, has just been named as one of the 2023 World’s Most Innovative Companies by Fast Company Magazine.

According to Fast Company Magazine, “This year’s list highlights the businesses at the forefront of their respective industries, paving the way for the innovations of tomorrow. These companies are setting the standard with some of the greatest accomplishments of the modern world.”

Xenco Medical Founder and CEO Jason Haider accepted the award from Fast Company on behalf of Xenco Medical at an awards ceremony in New York City on April 19th.

“We are deeply honored to be recognized as one of the World’s Most Innovative Companies by Fast Company and look forward to advancing the interdisciplinary breakthroughs encapsulated in each of our surgical technologies as we address the entire continuum of a patient’s journey,” said Jason Haider to OTW.

Xenco’s innovations include a biomimetic titanium foam spinal implants as well as the world’s first glasses-free holographic surgical simulation platform. The company also designed an Ambulatory Surgery Center (ASC) spine kit named Multilevel CerviKit. According to Xenco, the kit gives ASC surgeons a range of implants and single-use instruments for two, three, and four level anterior cervical spine procedures. Of course, as a disposable kit, sterilization is included in the kit.

“Bridging seemingly disparate fields in our development of comprehensive spinal technologies, we’ve thrived on developing and scaling transformative technologies rooted in materials science, bioengineering, and computer science that work in concert towards value-based treatments for cervical, thoracic, and lumbar spine pathologies,” Haider told OTW. “We’ve remained steadfast in lowering costs and expanding care for the entire spectrum of spine surgery patients by using innovation to directly address antiquated systems rife with inefficiencies,” added Haider.

Advertisement

“From the unique interfacial bond strength that ensures the resiliency and disposability of our single-use spinal systems to the optimized ray-casting algorithm that underpins our glasses-free holographic surgical simulation platform and beyond, each of our technologies have been designed within an outcomes-oriented framework to amplify the impact of physicians and healthcare facilities on their respective communities,” noted Haider.

Another “first” for the company is its WiFi-enabled surgical vending machines for real-time inventory monitoring of Xenco Medical’s implant systems. The company offers a large portfolio of sterile-packaged spinal implants pre-attached to disposable, composite polymer delivery instruments. According to the publication, “Fast Company’s editors and writers sought out the companies making the biggest strides around the globe.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy